Delivery Order SPE2DR25D2206-SPE2DR26F9EE7
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $9,003.87 by the Defense Logistics Agency (DLA) on August 13, 2025, for the supply of Gemtesa 75 mg tablets (90-count package). This competitive award is structured as a firm fixed price delivery order with an ultimate completion date of August 14, 2025, and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on July 21, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $16,491.74. This firm fixed-price delivery order, which is due for completion by July 22, 2025, represents a pharmaceutical supply requirement under DLA's medical procurement operations. The award was competitively awarded with no set-aside designation, and AmerisourceBergen will perform the work at its...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $25,148.50 for 90-tablet supplies of Gemtesa 75 mg tablets under a firm fixed-price contract. The award, made on September 15, 2025, with an ultimate completion date of September 16, 2025, represents a competitively awarded, non-set-aside procurement. Performance of this delivery order is based in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency for Gemtesa 75 mg tablets (30-count units) with a ceiling value of $96,726.89 under a firm fixed-price contract type. The award was made on November 3, 2025, with an ultimate completion date of November 4, 2025, and represents a non-set-aside competitive procurement. The place of performance is located at the contractor's corporate office in Conshohocken, PA....
- The Defense Logistics Agency awarded a $1,078.72 delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Gemtesa 75 mg tablets (90-count package). This firm fixed-price, competitively awarded contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. The place of performance is AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $15,914.07 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on December 4, 2025, with completion expected by December 5, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance based in Conshohocken, Pennsylvania, where the contractor maintains its corporate headquarters. The award falls under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $58,139.09 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (90-count supply) on December 4, 2025, with completion targeted for December 5, 2025. This non-set-aside, firm fixed-price delivery order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement action under the company's existing contract vehicle with DLA. This delivery...
- The Defense Logistics Agency awarded a $27,132.48 delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Gemtesa 75 mg tablets (90-count packages). This firm fixed-price, non-set-aside contract is scheduled for completion by December 3, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader indefinite delivery contract with DLA Troop...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $57,339.96 on September 5, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 8, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $15,433.83 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count packages) with a completion date of November 25, 2025. This competitively awarded, firm fixed-price delivery order represents a non-set-aside contract with the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. The award falls under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9EE7Delivery Order
AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,590.20 by the Defense Logistics Agency on December 3, 2025, for the supply of Gemtesa 75 mg tablets (90-count). This firm fixed-price, non-set-aside contract is scheduled for completion by December 4, 2025, with performance taking place at the awardee's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order under a larger contract vehicle supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for military and veteran healthcare systems, AmerisourceBergen Drug Corp leverages this comprehensive global pharmaceutical support vehicle to supply a broad range of medications, vaccines, and medical supplies across multiple therapeutic domains to government healthcare customers, including the Defense Health Agency and U.S. Coast Guard. The company's demonstrated capability to fulfill federal medical supply requirements through competitive procurement is reflected in its consistent receipt of non-set-aside delivery orders across its extensive pharmaceutical product portfolio.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $27.6k | 12/2/25 |